Completed
Safety and Reactogenicity of GlaxoSmithKline (GSK) Biologicals' IPV Vaccine (PoliorixTM) in Toddlers
NCT00920439
- Conditions
- Central Nervous System Diseases, Central Nervous System Infections, Enterovirus Infections, +10 more
- Locations
-
- GSK Investigational Site Wuzhou, Guangxi, China